Vontobel Holding
SPRY icon

Vontobel Holding’s ARS Pharmaceuticals SPRY Stock Holding History

Vontobel Holding’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-260,684
Closed -$985K – 1163
2023
Q3 		$985K Sell
260,684
-83,345
-24% -$547K 0.01% 586
2023
Q2 		$2.3M Buy
344,029
+174,297
+103% +$1.16M 0.02% 417
2023
Q1 		$1.1M Buy
169,732
+23,881
+16% +$183K 0.01% 560
2022
Q4 		$1.2M Buy
+145,851
New +$946K 0.01% 527

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
CST
Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vontobel Holding's SPRY Position: Q4 2023 in Review

Vontobel Holding sold out of ARS Pharmaceuticals (SPRY) in Q4 2023, closing a stake of 260,684 shares — an estimated $985K sold.

Vontobel Holding first reported a position in SPRY in Q4 2022 and held it in 4 quarters. The position peaked at $2.3M in Q2 2023. 100 funds tracked by Wall St. Rank hold SPRY as of Q4 2023.

  • Vontobel Holding reported no remaining ARS Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Vontobel Holding sold 260,684 ARS Pharmaceuticals shares in Q4 2023, an estimated $985K.
  • Vontobel Holding first reported a position in ARS Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Vontobel Holding's ARS Pharmaceuticals position peaked at $2.3M in Q2 2023.
  • 100 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q4 2023.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.